UNASSIGNED: @entity101 is the leading cause of @entity204 in developed countries; its management is the subject of guidelines that are regularly reviewed and updated. However, the guidelines from France, the UK, Europe and the USA differ. Some recommendations are graded, whereas others are not. All recommendations emphasize the role of alternative methods for clinical measurement of blood pressure, such as ambulatory blood pressure measurement (ABPM) or self-measurement. The UK guideline recommends that the diagnosis of @entity101 should be established by ABPM. The USA guideline recommends a target of  <=  150/90mmHg for @entity1 aged>60  years. The French guideline recommends that the target blood pressure remains at<140/90mmHg, with<150mmHg for @entity1 aged>80 years. Systolic blood pressure between 130 and 139mmHg and diastolic blood pressure<90mmHg are recommended for @entity6 @entity1 and those with @entity740 . The French Society of @entity101 (SFHTA) guideline is unique in recommending a dedicated consultation to announce the diagnosis to the @entity1 . In the French and European guidelines, diuretics, beta-blockers, @entity460 antagonists, @entity7774 -converting enzyme (ACE) inhibitors and angiotensin II type 1 receptor blockers (ARBs) remain indicated as first-line therapy for @entity101 ; if the target blood pressure is not achieved, they recommend combining two active substances. The UK guideline recommends ACE inhibitors or ARBs as first-line therapy for @entity1 aged<55  years; @entity460 antagonists are advised for @entity1 aged>55  years and for black @entity1 . The USA guideline advises treating @entity7864 @entity1 , including those with @entity6 , with @entity7206 , @entity460 antagonists, ACE inhibitors or ARBs; for black @entity1 , including those with @entity6 , it recommends @entity6662 and @entity460 antagonists.

A critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of XXXX in adults.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity7864 :: ('MESH:D055008', 'Disease') :: ['non-black'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension', 'Hypertension'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetic', 'diabetes'] @entity7774 :: ('MESH:D000809', 'Chemical') :: ['angiotensin'] @entity740 :: ('MESH:D051436', 'Disease') :: ['chronic kidney disease'] @entity6662 :: ('D049971', 'Chemical') :: ['thiazide'] @entity7206 :: ('MESH:D049971', 'Chemical') :: ['thiazides'] @entity460 :: ('MESH:D002118', 'Chemical') :: ['calcium'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity101 :: (MESH:D006973,Disease) :: ['hypertension']
